Showing 5301 - 5310 of 5334 for "United Kingdom (England)" with applied filters
01 September 2018 by Karen Artz Ash
In the last few years, the US Supreme Court has held that laches is not an available defense to claims for copyright or patent infringement brought within the limited periods described under each of the Copyright and Patent Acts
31 August 2018 by Managing Intellectual Property
The decision of the Full Federal Court in GlaxoSmithKline (GSK) Consumer Healthcare Investments (Ireland) (No 2) Limited v Generic Partners Pty Limited (2018) FCAFC 71 (May 10 2018) indicates that a mistake in a claim cannot be ignored even where the skilled person understands that a mistake has been made.
04 July 2018 by Managing Intellectual Property
Meet with start-up founders, entrepreneurs, investors, corporate and brand executives, and thought leaders at unbound London festival
02 July 2018 by Managing Intellectual Property
In FIL Ltd & Anor v Fidelis Underwriting Ltd & Ors [2018] EWHC 1097 (Pat), it was held that use of FIDELIS for insurance underwriting does not infringe FIDELITY for insurance or financial services.
02 July 2018 by Sybille Pfender
At the end of April 2018, Advocate General (AG) Wathelet handed down an advisory opinion regarding the first of three recent referrals to the CJEU (C-121/17). This concerns the interpretation of Article 3(a) of Regulation (EC) No 469/2009.
02 July 2018 by Managing Intellectual Property
CRISPR technology enables genes to be edited and can eventually treat diseases caused by gene mutations.
02 July 2018 by Karen Artz Ash
Although it is the general policy of the USPTO’s Trademark Trial and Appeal Board (TTAB) to suspend opposition proceedings when the parties to such proceedings become involved in a civil action which may be dispositive of the case, a recent decision issued by the US District Court for the District of Delaware in Tigercat Int’l, Inc. v Caterpillar Inc. indicates that there are circumstances where, conversely, federal courts will stay a litigation pending a TTAB ruling.
01 June 2018 by Managing Intellectual Property
The Intellectual Property Enterprise Court (IPEC) has an objective to provide quick and cost-effective IP litigation. It has proved to be popular.
01 June 2018 by Henri van Kalkeren
Cialis® is a pharmaceutical product for the treatment of erectile dysfunction developed by Lilly ICOS, a joint venture of ICOS Corporation and Eli Lilly and Company.
01 June 2018 by Mark Davis
Trade mark owners should feel encouraged by the Ontario Court of Appeal’s decision to enforce an agreement to prevent grey marketing (or parallel importing) in Mars Canada Inc v Bemco Cash & Carry Inc.